H1 Secures $40M From CVS, Proving SaaS Startups Can Still Attract Investment

H1 Secures $40M From CVS, Proving SaaS Startups Can Still Attract Investment

H1 Secures $40M as Healthcare SaaS Defies AI Slowdown The AI investment boom has made life difficult for many traditional software startups, but healthcare data company H1 is proving that specialized SaaS businesses can still attract major investor attention. H1 recently secured $40 million in fresh funding from CVS Health Ventures, signaling continued confidence in healthcare-focused data platforms even as venture capital increasingly shifts toward artificial intelligence startups. The funding round arrives at a time when many investors are pulling back from older SaaS models. Companies that once dominated venture capital conversations are now competing against fast-growing AI startups commanding massive valuations and media attention. Yet H1’s latest raise suggests that businesses built around proprietary healthcare data may still hold a strong position in the evolving tech landscape. H1’s $40M Funding Signals Confidence in Healthcare Data H1 has spent nearly a decade building a healthc…